OOIR: Observatory of International Research

Papers

(The H4-Index of European Journal of Internal Medicine is 35. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Electrocardiographic changes associated with hypothermia	239
Sodium-glucose cotransporter2 inhibitor-associated ketoacidosis in nondiabetic patients	218
Non-pharmacological home remedies used by primary care patients	159
Effects of the implementation of the dynamic silver code in the emergency department	146
The role of age in recognizing cognitive impairment in the emergency department	137
Concerns regarding result analysis and the corresponding risk of pulmonary embolism severity and in-hospital mortality	131
How the theory of centralized aerobic-anaerobic energy balance compensation explains sudden cardiac death in young athletes	105
Effects of statins on clinical outcomes in hospitalized patients with COVID-19	97
Heart failure: An autopsy case	80
Natural history of ‘silent’ atrial fibrillation from subclinical to asymptomatic: State of the art and need for research	77
Efficacy and safety assessment of mineralocorticoid receptor antagonists in patients with chronic kidney disease	74
A woman with purple-brown skin lesions after immunosuppressive therapy	71
The peculiarities of COVID-19 in older people: Considerations after two years	71
Health differences between adults with and without intellectual disabilities at the internal medicine department: A first step to improve awareness of intellectual disabilities among healthcare profes	69
Abdominal aortic aneurysm and gas in the kidney in a diabetes patient	66
A call to action: The need to apply guidelines recommendations with ABC or SOS to improve stroke prevention and cardiovascular outcomes in patients with atrial fibrillation	66
Internists or specialists-that is the question!	60
Structural evolution of severe acute respiratory syndrome coronavirus 2: Implications for adhesivity to angiotensin-converting enzyme 2 receptors and vaccines	56
No evidence of a “July Effect” on mortality	54
Impact of adherence to EULAR quality indicators on the quality of life of patients with systemic lupus erythematosus	53
Optimal duration of anticoagulation therapy for venous thromboembolism in autoimmune diseases	46
Uncomplicated outpatient deep venous thrombosis management with a novel care pathway: Is it ready for prime time?	46
Impact of L-arginine and liposomal vitamin C supplementation on quality of life and daily life activities in patients with COPD: a randomized, multicenter, single blind, placebo-controlled trial (ILDA	44
A man with brown macules on the limbs	44
A systematic review and meta-analysis of all sham and placebo controlled trials for resistant hypertension	43

Prevalence of post-COVID symptoms one-year after SARS-CoV-2 infection in patients with interstitial lung disease	40
Refining risk assessment for intra-abdominal infections in immunocompromised intensive care unit patients	40
Refining metabolic health assessment in inflammatory bowel disease risk prediction	40
Prognostic impact of hypertension grading	38
Recurrent vomiting	37
Potential mechanisms of vaccine-induced thrombosis	37
Trial sequential analysis methodology for interpreting meta-analytical findings	36
Considerations on socioeconomic and hormonal factors in sex- and gender-specific risk of metabolic syndrome	36
Reconsidering the Edelman equation: impact of plasma sodium concentration, edema and body weight	35
Oral semaglutide in HFpEF: Real-world evidence and causal considerations	35
Endothelin-1 as dual marker for renal function decline and associated cardiovascular complications in patients with chronic kidney disease	35